푸마 바이오테크놀로지, Inc.
US ˙ NasdaqGS ˙ US74587V1070

SecurityPBYI / Puma Biotechnology, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership3,422 shares
Latest Disclosed Value $ 21,866
Citigroup Inc ownership in PBYI / Puma Biotechnology, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 3,422 shares of Puma Biotechnology, Inc. (US:PBYI) valued at $21,867 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,380 shares of Puma Biotechnology, Inc.. This represents a change in shares of 43.78% during the quarter. The current value of the position is $23,988 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (PBYI) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PBYI / Puma Biotechnology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 3,422 1,042 43.78 22 50.00 0.0000
2026-02-13 2025-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 2,380 1,521 177.07 14 250.00 0.0000
2025-11-10 2025-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 859 -13,461 -94.00 5 -91.84 0.0000
2025-08-11 2025-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 14,320 -15,147 -51.40 49 -43.68 0.0000
2025-05-12 2025-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 29,467 -3,794 -11.41 87 -13.86 0.0000
2025-02-12 2024-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 33,261 3,213 10.69 101 32.89 0.0001
2024-11-12 2024-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 30,048 10,188 51.30 77 18.75 0.0000
2024-08-12 2024-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 19,860 -110,613 -84.78 65 -90.74 0.0000
2024-05-10 2024-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 130,473 -40,580 -23.72 692 -6.62 0.0005
2024-02-09 2023-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 171,053 71,286 71.45 741 182.44 0.0005
2023-12-06 2023-09-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 99,767 99,767 262 0.0002
2023-11-09 2023-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 99,767 99,767 262 0.0001
2023-05-11 2023-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 0 -26,473 -100.00 0 -100.00
2023-02-09 2022-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 26,473 25,925 4,730.84 112 11,000.00 0.0001
2022-11-10 2022-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 548 -429 -43.91 1 -66.67 0.0000
2022-08-10 2022-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 977 -1,107 -53.12 3 -50.00 0.0000
2022-05-12 2022-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 2,084 -7,141 -77.41 6 -78.57 0.0000
2022-02-10 2021-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 9,225 3,114 50.96 28 -34.88 0.0000
2021-11-10 2021-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 6,111 -86,042 -93.37 43 -94.92 0.0000
2021-08-10 2021-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 92,153 -83,099 -47.42 846 -50.35 0.0005
2021-05-13 2021-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 175,252 128,294 273.21 1,704 253.53 0.0011
2021-02-11 2020-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 46,958 4,984 11.87 482 13.95 0.0003
2020-11-12 2020-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 41,974 -53,770 -56.16 423 -57.62 0.0003
2020-08-12 2020-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 95,744 -41,700 -30.34 998 -13.89 0.0008
2020-05-12 2020-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 137,444 -69,085 -33.45 1,159 -35.90 0.0010
2020-02-12 2019-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 206,529 -16,167 -7.26 1,808 -24.57 0.0013
2019-11-08 2019-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 222,696 -119,417 -34.91 2,397 -44.88 0.0019
2019-08-12 2019-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 342,113 304,753 815.72 4,349 199.93 0.0035
2019-05-13 2019-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 37,360 -253,810 -87.17 1,450 -75.53 0.0014
2019-02-12 2018-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 291,170 253,253 667.91 5,926 240.77 0.0060
2018-11-13 2018-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 37,917 6,522 20.77 1,739 -6.30 0.0016
2018-08-10 2018-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 31,395 18,525 143.94 1,856 111.63 0.0017
2018-05-11 2018-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 12,870 -55,600 -81.20 877 -87.04 0.0007
2018-02-12 2017-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 68,470 38,905 131.59 6,768 91.19 0.0054
2017-11-13 2017-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 29,565 -36,197 -55.04 3,540 -38.40 0.0029
2017-08-11 2017-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 65,762 1,846 2.89 5,747 141.78 0.0052
2017-05-12 2017-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 63,916 -142,958 -69.10 2,377 -62.57 0.0021
2017-02-10 2016-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 206,874 204,579 8,914.12 6,351 4,024.03 0.0057
2016-11-10 2016-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 2,295 4 0.17 154 126.47 0.0001
2016-08-12 2016-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 2,291 -889 -27.96 68 -27.66 0.0001
2016-05-13 2016-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 3,180 -5,903 -64.99 94 -86.80 0.0001
2016-02-12 2015-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 9,083 -2,582 -22.13 712 -19.00 0.0007
2015-11-13 2015-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 11,665 7,274 165.66 879 72.02 0.0008
2015-08-13 2015-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 4,391 524 13.55 511 -44.03 0.0005
2015-05-14 2015-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 3,867 -4,630 -54.49 913 -43.22 0.0009
2015-02-17 2014-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 8,497 3,877 83.92 1,608 45.92 0.0014
2014-11-14 2014-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 4,620 -947 -17.01 1,102 200.27 0.0010
2014-08-14 2014-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 5,567 -2,026 -26.68 367 -53.60 0.0004
2014-05-15 2014-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 7,593 132 1.77 791 2.46 0.0008
2014-02-14 2013-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 7,461 6,669 842.05 772 1,738.10 0.0007
2013-11-14 2013-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 792 792 42 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-13 2021-03-31 13F PUMA BIOTECHNOLOGY COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F PUMA BIOTECHNOLOGY COM Call 31,800 88.17 326 90.64 n/a n/a n/a
2020-11-12 2020-09-30 13F PUMA BIOTECHNOLOGY COM Call 16,900 -18.36 171 -20.83 n/a n/a n/a
2020-08-12 2020-06-30 13F PUMA BIOTECHNOLOGY COM Call 20,700 -35.31 216 -20.00 n/a n/a n/a
2020-05-12 2020-03-31 13F PUMA BIOTECHNOLOGY COM Call 32,000 -67.94 270 -69.07 n/a n/a n/a
2020-02-12 2019-12-31 13F PUMA BIOTECHNOLOGY COM Call 99,800 5.83 873 -13.99 n/a n/a n/a
2019-11-08 2019-09-30 13F PUMA BIOTECHNOLOGY COM Call 94,300 57.69 1,015 33.55 n/a n/a n/a
2019-08-12 2019-06-30 13F PUMA BIOTECHNOLOGY COM Call 59,800 13.04 760 -62.96 n/a n/a n/a
2019-05-13 2019-03-31 13F PUMA BIOTECHNOLOGY COM Call 52,900 294.78 2,052 651.65 n/a n/a n/a
2019-02-12 2018-12-31 13F PUMA BIOTECHNOLOGY COM Call 13,400 100.00 273 -11.07 n/a n/a n/a
2018-11-13 2018-09-30 13F PUMA BIOTECHNOLOGY COM Call 6,700 -61.93 307 -70.51 n/a n/a n/a
2018-08-10 2018-06-30 13F PUMA BIOTECHNOLOGY COM Call 17,600 -26.05 1,041 -35.74 n/a n/a n/a
2018-05-11 2018-03-31 13F PUMA BIOTECHNOLOGY COM Call 23,800 52.56 1,620 5.06 n/a n/a n/a
2018-02-12 2017-12-31 13F PUMA BIOTECHNOLOGY COM Call 15,600 1.30 1,542 -16.38 n/a n/a n/a
2017-11-13 2017-09-30 13F PUMA BIOTECHNOLOGY COM Call 15,400 -44.80 1,844 -24.36 n/a n/a n/a
2017-08-11 2017-06-30 13F PUMA BIOTECHNOLOGY COM Call 27,900 381.03 2,438 1,028.70 n/a n/a n/a
2017-05-12 2017-03-31 13F PUMA BIOTECHNOLOGY COM Call 5,800 -74.22 216 -68.74 n/a n/a n/a
2017-02-10 2016-12-31 13F PUMA BIOTECHNOLOGY COM Call 22,500 -28.12 691 -67.08 n/a n/a n/a
2016-11-10 2016-09-30 13F PUMA BIOTECHNOLOGY COM Call 31,300 501.92 2,099 1,254.19 n/a n/a n/a
2016-08-12 2016-06-30 13F PUMA BIOTECHNOLOGY COM Call 5,200 5,100.00 155 5,066.67 n/a n/a n/a
2016-05-13 2016-03-31 13F PUMA BIOTECHNOLOGY COM Call 100 -95.00 3 -98.09 n/a n/a n/a
2016-02-12 2015-12-31 13F PUMA BIOTECHNOLOGY COM Call 2,000 5.26 157 9.79 n/a n/a n/a
2015-11-13 2015-09-30 13F PUMA BIOTECHNOLOGY COM Call 1,900 143 n/a n/a n/a
2015-02-17 2014-12-31 13F PUMA BIOTECHNOLOGY COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F PUMA BIOTECHNOLOGY COM Call 30,000 7,157 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-13 2021-03-31 13F PUMA BIOTECHNOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F PUMA BIOTECHNOLOGY COM Put 61,800 -7.76 634 -6.21 n/a n/a n/a
2020-11-12 2020-09-30 13F PUMA BIOTECHNOLOGY COM Put 67,000 -46.01 676 -47.76 n/a n/a n/a
2020-08-12 2020-06-30 13F PUMA BIOTECHNOLOGY COM Put 124,100 -2.13 1,294 20.93 n/a n/a n/a
2020-05-12 2020-03-31 13F PUMA BIOTECHNOLOGY COM Put 126,800 -20.25 1,070 -23.08 n/a n/a n/a
2020-02-12 2019-12-31 13F PUMA BIOTECHNOLOGY COM Put 159,000 58.37 1,391 28.68 n/a n/a n/a
2019-11-08 2019-09-30 13F PUMA BIOTECHNOLOGY COM Put 100,400 231.35 1,081 180.78 n/a n/a n/a
2019-08-12 2019-06-30 13F PUMA BIOTECHNOLOGY COM Put 30,300 71.19 385 -43.96 n/a n/a n/a
2019-05-13 2019-03-31 13F PUMA BIOTECHNOLOGY COM Put 17,700 -51.51 687 -7.54 n/a n/a n/a
2019-02-12 2018-12-31 13F PUMA BIOTECHNOLOGY COM Put 36,500 244.34 743 52.88 n/a n/a n/a
2018-11-13 2018-09-30 13F PUMA BIOTECHNOLOGY COM Put 10,600 -20.30 486 -38.25 n/a n/a n/a
2018-08-10 2018-06-30 13F PUMA BIOTECHNOLOGY COM Put 13,300 166.00 787 131.47 n/a n/a n/a
2018-05-11 2018-03-31 13F PUMA BIOTECHNOLOGY COM Put 5,000 -76.85 340 -84.07 n/a n/a n/a
2018-02-12 2017-12-31 13F PUMA BIOTECHNOLOGY COM Put 21,600 0.93 2,135 -16.70 n/a n/a n/a
2017-11-13 2017-09-30 13F PUMA BIOTECHNOLOGY COM Put 21,400 -14.74 2,563 16.82 n/a n/a n/a
2017-08-11 2017-06-30 13F PUMA BIOTECHNOLOGY COM Put 25,100 105.74 2,194 383.26 n/a n/a n/a
2017-05-12 2017-03-31 13F PUMA BIOTECHNOLOGY COM Put 12,200 -45.29 454 -33.72 n/a n/a n/a
2017-02-10 2016-12-31 13F PUMA BIOTECHNOLOGY COM Put 22,300 137.23 685 8.73 n/a n/a n/a
2016-11-10 2016-09-30 13F PUMA BIOTECHNOLOGY COM Put 9,400 327.27 630 854.55 n/a n/a n/a
2016-08-12 2016-06-30 13F PUMA BIOTECHNOLOGY COM Put 2,200 -47.62 66 -46.34 n/a n/a n/a
2016-05-13 2016-03-31 13F PUMA BIOTECHNOLOGY COM Put 4,200 -76.27 123 -91.14 n/a n/a n/a
2016-02-12 2015-12-31 13F PUMA BIOTECHNOLOGY COM Put 17,700 378.38 1,388 397.49 n/a n/a n/a
2015-11-13 2015-09-30 13F PUMA BIOTECHNOLOGY COM Put 3,700 279 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.